Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Porphyrias

Y V Scarlett1, D A Brenner

  • 1Department of Medicine, University of North Carolina at Chapel Hill, 27599-7080, USA.

Journal of Clinical Gastroenterology
|November 5, 1998
PubMed
Summary
This summary is machine-generated.

The porphyrias are genetic metabolic disorders affecting heme biosynthesis, leading to porphyrin accumulation. This review covers heme pathway enzymes, clinical features, and management strategies for these complex diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Signal transduction during liver regeneration.

Journal of gastroenterology and hepatology·2017
Same author

Magnetic resonance elastography identifies fibrosis in adults with alpha-1 antitrypsin deficiency liver disease: a prospective study.

Alimentary pharmacology & therapeutics·2016
Same author

Novel association between serum pentraxin-2 levels and advanced fibrosis in well-characterised patients with non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2015
Same author

Physiologically based pharmacokinetic modeling framework for quantitative prediction of an herb-drug interaction.

CPT: pharmacometrics & systems pharmacology·2014
Same author

Evidence for a common progenitor of epithelial and mesenchymal components of the liver.

Cell death and differentiation·2013
Same author

Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2013
Same journal

GLP-1 Receptor Agonists and Hepatic Encephalopathy in Cirrhosis: A Protective Signal Requiring Cancer and Nutritional Phenotyping.

Journal of clinical gastroenterology·2026
Same journal

Endoscopic Incisional Therapy for Benign Esophageal Strictures: A Systematic Review and Meta-Analysis.

Journal of clinical gastroenterology·2026
Same journal

International Consensus Statements on the Use of Topical Endoscopic Hemostatic Powders in the Treatment of Acute Gastrointestinal Bleeding.

Journal of clinical gastroenterology·2026
Same journal

Do Risk Factors for Reflux Symptoms After Peroral Endoscopic Myotomy Necessarily Increase the Occurrence of Postoperative Gastroesophageal Reflux?

Journal of clinical gastroenterology·2026
Same journal

Subgroup Stratification by Regimen, Geography, and Population Is Necessary to Validate Nitazoxanide-based Helicobacter pylori Eradication Therapy.

Journal of clinical gastroenterology·2026
Same journal

The Impact of Glucagon-Like Peptide 1 Receptor Agonists Versus Diabetes Mellitus on Endoscopic Procedures: A Case-Control Study From a Large Tertiary Care Health System.

Journal of clinical gastroenterology·2026
See all related articles

Area of Science:

  • Biochemistry
  • Metabolic Disorders
  • Genetics

Background:

  • Porphyrias are a diverse group of inherited metabolic diseases.
  • These disorders stem from genetic defects in heme biosynthesis enzymes.
  • Characterized by abnormal accumulation and excretion of porphyrins or their precursors.

Purpose of the Study:

  • To review the enzymes within the heme biosynthetic pathway.
  • To describe the clinical manifestations of various porphyrias.
  • To outline current management approaches for patients with porphyrias.

Main Methods:

  • Literature review of porphyria pathogenesis and clinical studies.
  • Synthesis of information on heme biosynthesis enzymes.
  • Compilation of data on clinical classification and treatment.

Related Experiment Videos

Main Results:

  • Detailed description of each enzyme in the heme biosynthetic pathway.
  • Classification of porphyrias into cutaneous, hepatic, and neuropsychiatric types.
  • Overview of the distinct clinical features associated with each porphyria type.

Conclusions:

  • Understanding heme biosynthesis is crucial for diagnosing porphyrias.
  • Effective management requires tailored approaches based on disease type and severity.
  • Further research can improve therapeutic strategies for these rare metabolic disorders.